Scancell Holdings (SCLP)

 

SCLP Share PerformanceMore

52 week high21.360 10/06/16
52 week low11.585 27/04/17
52 week change -3.875 (-24.03%)
4 week volume3,300,465 04/04/17

Media for (SCLP)

Presenter: Dr Richard Goodfellow
31/07/2015
Presenter: Dr Richard Goodfellow
02/06/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Scancell changes registered office

Scancell Holdings has changed its registered office address to John Eccles House, Robert Robinson Avenue, Oxford Science...

Change of Registered Office

RNS Number: 4811C Scancell Holdings Plc 13 April 2017 13 April 2017 Scancell Holdings Plc ("Scancell" or the "Company") Change of Registered Office Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, announces that it has changed its registered office address. The new registered office address for ...

Immuno-Oncology Summit Europe 2017

RNS Number: 8784Z Scancell Holdings Plc 20 March 2017 20 March 2017 Scancell Holdings Plc ("Scancell" or the "Company") Scancell to present at the Immuno-Oncology Summit Europe 2017 Professor Lindy Durrant, Scancell's CSO, to chair and present in a session entitled: "Combining Checkpoint Inhibitors with Other Modalities" Scancell Holdings plc, ('Scancell' o...

Scancell eyes fundraising for Phase II SCIB1 trial

Scancell Holdings said that in 2017 it will concentrate on raising the necessary funds to enable the commencement of a Pha...

Hardman Research: SCIB development update

RNS Number: 2051Z Scancell Holdings Plc 13 March 2017 Hardman Research: SCIB development update SCIB development update: Scancell is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high avidity anti-tumour T-cells for u...

Holding(s) in Company

RNS Number: 1310Y Scancell Holdings Plc 01 March 2017 TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Scancell Holdings Plc 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights An acquisition or disposal of...

Scancell widens H1 pretax loss

Scancell has widened its H1 pretax loss to 2.1m, from a year-earlier loss of 1.4m, adding 2017 is set to be an important and bu...

Interim Results

RNS Number: 5212V Scancell Holdings Plc 31 January 2017 31 January 2017 Scancell Holdings Plc ("Scancell" or the "Company") Interim Results for the 6 months ended 31 October 2016 Strong progress continues across all clinical programmes; planning to start US SCIB1 Phase 2 combination study in H2 2017 Scancell Holdings plc, ('Scancell' or the 'Company') the develo...

Fundamental DataMore

EPS-1.14
Dividend yield0 %

Equity Research (SCLP)

hardman & co
Scancell Holdings PLC
17/03/2017
Scancell is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high...
hardman & co
Scancell Holdings PLC
26/09/2016
Scancell is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high...

Latest discussion posts More

  • Re: Fund raising result

    Yesterday might of been bottom this was a Nigel Somerville ( SP ) tip 19 June 2016. Seems his boss wasn't to keen on it and has been proved a better picker with this ...
    28-Apr-2017
    Ripley94
  • Re: Fund raising result

    Not looking good 11 months after OO. big drop of 11% today now 11.5p Talk of another fund raise. Maybe that will be a placing this time ?
    27-Apr-2017
    Ripley94
  • Re: The penny drops

    Since my last post here, the S P sat then at circa 15.63p {mid}.... Despite ALL the "Deals ANY DAY now' and other 'promises by the blind-faithers'.... S P now = ???. FUNDING ...
    21-Feb-2017
    kipngail

Users' HoldingsMore

Users who hold Scancell Holdings also hold..
LLOYDS GRP.17%
SIRIUS MINERALS15%
TESCO12%
PREMAITHA11%
GLAXOSMITHKLINE10%

Codes & Symbols

ISINGB00B63D3314
SymbolsSCLP, LSE:SCLP, SCLP.L, SCLP:LN, LON:SCLP, XLON:SCLP